GO
Loading...

Covidien PLC

More

  • UPDATE 2-St. Jude not keen to join inversion deal craze Wednesday, 16 Jul 2014 | 3:39 PM ET

    In the most recent such deal in the medical device sector, Medtronic Inc last month agreed to buy Covidien for $43 billion. The move will allow Medtronic to re-domicile to Ireland to take advantage of low corporate tax rates and to access cash overseas without having to pay high repatriation costs.

  • Treasury Secretary Jacob Lew urged Congress on Wednesday to take steps quickly to discourage U.S. companies from moving their tax domiciles abroad to avoid federal taxes. "Congress should enact legislation immediately," Lew told a business conference in New York hosted by cable television channel CNBC.

  • FACTBOX-M&A frenzy transforming global pharma Monday, 14 Jul 2014 | 9:27 AM ET

    July 14- Several multi-billion dollar deals and bids have made 2014 a busy year for healthcare acquisitions, despite Pfizer pulling its $118 billion offer for AstraZeneca.

  • July 11- Medical device maker Covidien Plc said it recorded a pre-tax charge of about $180 million for the third quarter, related to litigation against some manufacturers of pelvic mesh products. Covidien said it was indemnifying the manufacturer on certain claims.

  • July 11- Medical device maker Covidien Plc said it recorded a pre-tax charge of about $180 million for the third quarter, related to litigation against some manufacturers of pelvic mesh products. The company's two units supplied pelvic mesh products to one of the manufacturers named in the lawsuit and is indemnifying that manufacturer on certain claims.

  • Medical technology group Medtronic Inc said last month that it plans to buy Covidien Plc, a rival based in low-tax Ireland. The research service said other inversions have been done in the past decade by Mallinckrodt Pharmaceuticals, Perrigo Co Plc, Actavis Plc and other companies, many of them rebasing for tax purposes to Ireland.

  • Walgreens

    Walgreen's chief, who said he was "proud of our Illinois heritage," is considering a deal that would move its HQ to Switzerland in a bid to cut taxes.

  • Let's make a deal! Global M&A at 7-year high Monday, 30 Jun 2014 | 6:21 AM ET
    Viagra made by Pfizer and Nexiam made by AstraZeneca.

    Investor support for large acquisitions and a desire to trump rivals in consolidating markets have led CEOs to strike big transactions in 2014.

  • NEW YORK, June 30- Investor support for large acquisitions and a desire to trump rivals in consolidating markets have led chief executives to strike big transactions so far in 2014, raising year-to-date global deal volumes to their highest level in seven years.

  • BOSTON, June 20- Medtronic Inc, the world's largest stand-alone medical device maker, said on Friday it was the victim of a cyber attack last year.

  • LONDON, June 20- British drugmaker Shire has rejected a 27 billion-pound takeover offer from AbbVie, the latest attempt by a U.S. healthcare firm to tap into the London- listed group's low tax rate. Abbvie's takeover offer proposed creating a new U.S.-listed holding company with a UK tax domicile in a so-called "inversion" move.

  • As M&A heats up, here are three takeover targets Wednesday, 18 Jun 2014 | 1:41 PM ET
    Bob Olstein

    If Bob Olstein is right, the climate for takeovers is just beginning to heat up.

  • WASHINGTON, June 17- U.S. medical device maker Medtronic's plan to buy rival Covidien and move its base to Ireland is a sign that something is wrong with the U.S. tax system, a top Obama administration official said on Tuesday.

  • WASHINGTON, June 17- The U.S. Senate's chief tax law writer on Tuesday vowed to work on overhauling the federal tax code by August 2015, citing a move by Medtronic Inc to shift its tax home base to Ireland as a spur to congressional action.

  • WASHINGTON, June 17- The U.S. Senate's chief tax law writer on Tuesday vowed to work on overhauling the federal tax code by August 2015, citing a move by Medtronic Inc to shift its tax home base to Ireland as a spur to congressional action.

  • Multiple analysts upgrade Medtronic     Tuesday, 17 Jun 2014 | 9:30 AM ET

    CNBC's David Faber and Jim Cramer dig into upgrades for Medtronic from multiple analysts after the company announced it was buying Covidien.

  • *Shire expecting to receive approaches, taps Citi- sources. LONDON, June 17- Shares in Shire hit a record high on Tuesday on expectations of a takeover as dealmaking sweeps the drugs sector, after Reuters reported the group had hired investment bank Citi as a defence adviser. Shire and Citi declined to comment.

  • WASHINGTON, June 16- The threat of U.S. tax revenue losses from Medtronic Inc's plan to buy rival Covidien Plc and move its base to Ireland is stoking concerns from lawmakers and the Obama administration about corporate tax "inversion" deals.

  • Cramer: Perfectly legal strategy for ducking taxes Monday, 16 Jun 2014 | 6:21 PM ET

    If anyone hates high taxes, it’s Jim Cramer. And he’s always looking for new ways to do something about them.

  • CHICAGO, June 16- Well before Medtronic Inc and Covidien Plc announced their $43 billion merger, the two medical device makers had reached common conclusions about how they needed to change. U.S.-based Medtronic on Sunday said it would buy Covidien and moving its executive headquarters to Ireland to take advantage of lower corporate tax rates.